Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
Objective: To describe the implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service and to be able to analyze the added value to pharmacotherapy. Methods: The implementation was carried out in June 2012 at a tertiary level Hospital, taking place in two periods:...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Grupo Aula Médica
2015-01-01
|
Series: | Farmacia Hospitalaria |
Subjects: | |
Online Access: | http://www.aulamedica.es/fh/pdf/7497.pdf |
id |
doaj-15499e96fdf244279f39cec1e8d345f6 |
---|---|
record_format |
Article |
spelling |
doaj-15499e96fdf244279f39cec1e8d345f62020-11-25T01:57:41ZengGrupo Aula MédicaFarmacia Hospitalaria1130-63432171-86952015-01-0139313714610.7399/fh.2015.39.3.7497Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy ServiceMaría de la Paz Pacheco Ramos0Ainhoa Elisa Arenaza Peña1Alejandro Santiago Pérez2Cristina Bilbao Gómez-Martino3María Dolores Zamora Barrios4María Lourdes Arias Fernández5Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Residente de Farmacia Hospitalaria. Hospital Clínico San Carlos. Madrid.Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Jefe de Servicio de Farmacia Hospitalaria. Hospital Clínico San Carlos. Madrid. Objective: To describe the implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service and to be able to analyze the added value to pharmacotherapy. Methods: The implementation was carried out in June 2012 at a tertiary level Hospital, taking place in two periods: 1- test period with the installation of the robot, with technical configuration of the equipment and validation of 29 active ingredients and the integration of electronic prescribing software with the robot application (9 months). 2- Usage period (22 months). On the other hand, training was given to pharmacists and nurses. The robot uses image recognition, barcode identification and gravimetric controls for proper operation. These checks provide information about the error ratio in the preparation, with a margin of ± 10%, which after a pilot study was restricted to a range of ±4%. The robot was programmed to recognize bags, infusion pumps, syringes and vials. The added value was assessed for 31 months by identifying preparation´s errors. Results: 11,865 preparations were made by the robot, which meant approximately 40% of all antineoplastic prepared from 29 different active ingredients. 1.12% (n=133) of the errors were identified by the robot and therefore didn´t reach the patient (negative desviation - 4%). These errors were corrected manually. Conclusion: The implementation of a robot in the preparation of antineoplastic drugs allows to identify errors therefore preventing them to arrive to the patient. This promotes safety and quality of the process, reducing the exposure to cytotoxic drugs from the manipulator http://www.aulamedica.es/fh/pdf/7497.pdfRoboticsAntineoplastic; Automation; Development; Production; Safety; Quality |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
María de la Paz Pacheco Ramos Ainhoa Elisa Arenaza Peña Alejandro Santiago Pérez Cristina Bilbao Gómez-Martino María Dolores Zamora Barrios María Lourdes Arias Fernández |
spellingShingle |
María de la Paz Pacheco Ramos Ainhoa Elisa Arenaza Peña Alejandro Santiago Pérez Cristina Bilbao Gómez-Martino María Dolores Zamora Barrios María Lourdes Arias Fernández Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service Farmacia Hospitalaria Robotics Antineoplastic ; Automation ; Development; Production ; Safety; Quality |
author_facet |
María de la Paz Pacheco Ramos Ainhoa Elisa Arenaza Peña Alejandro Santiago Pérez Cristina Bilbao Gómez-Martino María Dolores Zamora Barrios María Lourdes Arias Fernández |
author_sort |
María de la Paz Pacheco Ramos |
title |
Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service |
title_short |
Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service |
title_full |
Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service |
title_fullStr |
Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service |
title_full_unstemmed |
Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service |
title_sort |
implementation of a robot for the preparation of antineoplastic drugs in the pharmacy service |
publisher |
Grupo Aula Médica |
series |
Farmacia Hospitalaria |
issn |
1130-6343 2171-8695 |
publishDate |
2015-01-01 |
description |
Objective: To describe the implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service and to be able to
analyze the added value to pharmacotherapy. Methods: The implementation was carried out in June 2012 at a tertiary level Hospital, taking place in two periods: 1- test period with the installation of the robot, with technical configuration of the equipment and validation of 29 active ingredients and the integration of electronic prescribing software with the robot application (9 months). 2- Usage period (22 months). On the other hand, training was given to pharmacists and nurses. The robot uses image recognition, barcode identification and gravimetric controls for proper operation. These checks provide information about the error ratio in the preparation, with a margin of ± 10%, which after a pilot study was restricted to a range of ±4%. The robot was programmed to recognize bags, infusion pumps, syringes and vials. The added value was assessed for 31 months by identifying preparation´s errors. Results: 11,865 preparations were made by the robot, which meant approximately 40% of all antineoplastic prepared from 29 different active ingredients. 1.12% (n=133) of the errors were identified by the robot and therefore didn´t reach the patient (negative desviation - 4%). These errors were corrected manually. Conclusion: The implementation of a robot in the preparation of antineoplastic drugs allows to identify errors therefore preventing them to arrive to the patient. This promotes safety and quality of the process, reducing the exposure to cytotoxic drugs from the manipulator
|
topic |
Robotics Antineoplastic ; Automation ; Development; Production ; Safety; Quality |
url |
http://www.aulamedica.es/fh/pdf/7497.pdf |
work_keys_str_mv |
AT mariadelapazpachecoramos implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice AT ainhoaelisaarenazapena implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice AT alejandrosantiagoperez implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice AT cristinabilbaogomezmartino implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice AT mariadoloreszamorabarrios implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice AT marialourdesariasfernandez implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice |
_version_ |
1724973198817099776 |